Genomma Lab Internacional Sab De Cv Class BBMV: LAB/B

LAB/B: Q2 2024 delivered strong profit growth, margin expansion, and strategic M&A activity

· Issued by Genomma Lab Internacional Sab De Cv Class B

Q2 2024 saw robust profitability and margin expansion, with net income up 50.1% and EPS up 53.1% year-over-year. Strategic M&A, productivity gains, and strong segment performance in Mexico and the U.S. offset macro headwinds and FX volatility.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.